Skip to main content

Advertisement

Log in

Blackberry-induced hand-foot skin reaction to sunitinib

  • SHORT REPORT
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

An Erratum to this article was published on 18 February 2009

Summary

Sunitinib is an orally administered small molecule that was approved by the US Food and Drug Administration in January 2006 as monotherapy for the treatment of patients with advanced renal cell carcinoma (RCC) and patients with gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. Data pooled from multiple sunitinib dose-escalation trials showed that sunitinib is associated with various adverse events, with HFSR occurring in up to 20% of patients. We describe a 48-year-old woman with a history of metastatic colorectal cancer treated with single-agent sunitinib who developed pain and tenderness in areas of friction secondary to Blackberry use, and was diagnosed with trauma-induced hand-foot skin reaction (HFSR) secondary to sunitinib therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Rock EP, Goodman V, Jiang JX et al (2007) Food and drug administration drug approval summary: sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist 12(1):107–113. doi:10.1634/theoncologist.12-1-107

    Article  PubMed  CAS  Google Scholar 

  2. Tsai KY, Yang CH, Kuo TT et al (2006) Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma. J Clin Oncol 24(36):5786–5788. doi:10.1200/JCO.2006.08.6868

    Article  PubMed  Google Scholar 

  3. Wilkes GM, Doyle D (2005) Palmar-plantar erythrodysesthesia. Clin J Oncol Nurs 9(1):103–106. doi:10.1188/05.CJON.31-44

    Article  PubMed  Google Scholar 

  4. Eming SA, Krieg T (2006) Molecular mechanisms of VEGF-A action during tissue repair. J Investig Dermatol Symp Proc 11(1):79–86. doi:10.1038/sj.jidsymp.5650016

    Article  PubMed  CAS  Google Scholar 

  5. Robert C, Faivre S, Raymond E et al (2005) Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors? Ann Intern Med 143(4):313–314

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario E. Lacouture.

Additional information

M.E.L. is supported by a Zell Scholarship from the Robert H Lurie Cancer Center.

An erratum to this article can be found at http://dx.doi.org/10.1007/s10637-009-9226-8

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boone, S.L., Jameson, G., Von Hoff, D. et al. Blackberry-induced hand-foot skin reaction to sunitinib. Invest New Drugs 27, 389–390 (2009). https://doi.org/10.1007/s10637-008-9196-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-008-9196-2

Keywords

Navigation